Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Berberine wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
12 of 16 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
5 of 5 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Berberine and TUDCA have evidence — compare verdict strength side-by-side.
500mg 2-3x daily (1000-1500mg total)
With meals, Split into 2-3 doses
Berberine HCl capsules
250-500mg daily for general support; up to 1500mg for therapeutic use
With meals containing fat, Before or with fatty meals
TUDCA capsules (pure tauroursodeoxycholic acid)
4-12 weeks
8-12 weeks
First 2 weeks
If on diabetes medications
4-8 weeks
1-2 weeks
8-12 weeks
Clinical Efficacy of Curcumin, Resveratrol, Silymarin, and Berberine on Cardio-Metabolic Risk Factors Among Patients With Type 2 Diabetes Mellitus: A Systemic Review and Bayesian Network Meta-Analysis
Phytotherapy research : PTR (2025) · Meta analysis · n=1337
For HbA1c, silymarin was more effective than resveratrol (MD -2.08, 95%Cl -3.50 to -0.72) (P < 0.05).
Effects of berberine and barberry on selected inflammatory biomarkers in adults: A systematic review and dose-response meta-analysis of randomized clinical trials
Phytotherapy research : PTR (2023) · Meta analysis · n=1600
In addition, the non-linear analysis showed a significant lowering effect of berberine/barberry on IL-6 and TNF-α levels in doses <1000 mg/day and less than 5 weeks of intervention.
Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
JAMA network open (2025) · Rct · n=113
The study included 113 patients with T2D (mean [SD] age, 54.3 [10.6] years; 72 male [63.7%]) who were randomized.
The bile acid TUDCA and neurodegenerative disorders: An overview
Life sciences (2021) · Systematic review
The tauroursodeoxycholic acid (TUDCA), one of the acids found in bear bile, is a hydrophilic bile acid and naturally produced in the liver by conjugation of taurine to ursodeoxycholic acid (UDCA).
Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure
International journal of molecular sciences (2021) · Systematic review
The potential advantages of whole-food plant-based diets, moderation in salt intake, avoidance of phosphate additives, and regular exercise training and sauna sessions are also discussed.
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis: A randomized, double-blind, placebo-controlled phase 3 trial
JAMA Neurology (2020) · Rct · n=137
TUDCA-phenylbutyrate slowed functional decline by 2.32 points on ALSFRS-R score
Based on meta-analyses showing FPG reduction of 0.59-0.82 mmol/L and HbA1c reduction of 0.63%. Studies primarily used berberine HCl with low bioavailability. Effects require divided doses and may take 8-12 weeks.
Based on one phase 3 RCT in ALS showing modest functional improvement and systematic reviews suggesting neuroprotective effects. Effect size is conservative given single disease population study and limited human data for other neurological conditions.
AI-estimated from published studies. Interpret as directional guidance.
Berberine has a higher evidence score (9/10 vs 8.5/10) and wins in 2 of 3 categories.
Both Berberine and TUDCA score equally (95) for reduce inflammation.
No known interactions between Berberine and TUDCA have been documented in our database. However, always consult a healthcare provider before combining supplements.